See every side of every news story
Published loading...Updated

Targeting FDA user fees would leave agency gutted, experts say

  • After settling in as President Donald Trump's health secretary, Robert F. Kennedy Jr. Is considering fulfilling his promise to ban pharmaceutical ads on TV, a stance he has held for a long time.
  • Fueling this consideration is the belief that these ads contribute to overmedication and drive demand for expensive treatments, as the American Medical Association also called for a ban on drug ads and medical devices in 2015.
  • Pharmaceutical companies spent over $5.3 billion on local and national TV advertising from January to October 2024, a 10% increase from the previous year, representing 10-12% of total TV ad spending, while over $4 billion was spent in 2023.
  • According to iSpot, The Associated Press, The New York Times, TripleLift, and NextinMedia, Kennedy attributes the ads to making America the biggest consumers of pharmaceutical products, stating that 'they’re not making us healthier'.
  • Banning pharmaceutical ads could significantly impact TV networks' revenue, potentially leading pharmaceutical brands to shift towards digital ads, content partnerships, and influencer marketing, while the FDA introduced new rules last fall requiring clearer explanations of medication risks.
Insights by Ground AI
Does this summary seem wrong?

30 Articles

All
Left
4
Center
10
Right
5
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 53% of the sources are Center
53% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

KTVU FOX 2 broke the news in Oakland, United States on Tuesday, March 25, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.